Costco rises after price cuts on Kirkland staples and mixed benefit commentary

What happened

Costco (COST) rose 0.3% on October 5, 2026, after the company announced price reductions on Kirkland Signature staples and amid commentary about its Medicare-related insurance plans. The stock closed at $923.52 and traded at 0.8 times its 20-day average, leaving a market value of $408.29 billion. Market action for the session was ordinary for this stock, so the reporting focuses on developments around the company rather than treating those developments as the cause of the price change.

How big was the move

The stock’s rise of 0.3% equaled 0.3 times a typical daily move for this stock and came as the S&P 500 rose 0.7% on the day. Over the last five sessions the shares rose 0.1% while the S&P 500 rose 1.2%. The Consumer Defensive sector median fell 0.1% on the day, leaving Costco 0.4 percentage points better than the sector median. With a beta of 0.36, the stock tends to move less than the market.

The technical picture

Technically, the stock sat 1.7% above its 20-day moving average but 1.0% below its 50-day average and 4.0% below its 200-day average, and the 50-day average is below the 200-day average, a sign of a weak longer-term trend. The 14-day Relative Strength Index was 53, inside a neutral range between 30 and 70. The shares were 15.8% below their 52-week high, having fallen 0.2% over one month and 2.5% over three months, while rising 0.7% over one year. Over one year the stock lagged the S&P 500 by 15.0 percentage points. Volatility was 18% annualized over 60 days, lower than 69% of its own readings over five years.

Fundamentals and valuation

For the four quarters through August 30, 2026, Costco reported revenue of $303.15 billion, up 10.1% from a year earlier, and diluted earnings per share of $27.59, a 51.5% increase year over year. Gross margin held at 12.8% compared with a year earlier, while operating margin was 3.9%, up from 3.8% a year earlier. Free-cash-flow margin stood at 3.1% and return on invested capital was 18.6%. On the balance sheet, the company reported net cash of $11.63 billion.

Valuation metrics show the stock trading at 33.5 times trailing earnings and 40.5 times expected earnings, with a free-cash-flow yield of 2.3%. The price to trailing earnings reading is lower than 95% of its own readings over the past five years; the five-year median is 46.2 times earnings. Those figures highlight a stretched valuation relative to Costco’s five-year history even as recent profit growth has been strong. PromtFinance sector scores reflected that contrast: Value 39 (Weak), Growth 89 (Strong), Quality 74 (Positive) and Stability 99 (Exceptional).

Earnings and analyst expectations

Costco’s last report, on September 24, 2026, showed earnings per share of $6.75 versus $6.54 expected, 3.2% above estimates. That followed an average surprise of 2.0% above estimates over the last four reports and marked one consecutive quarter beating estimates. Typical two-day reactions after recent reports saw the stock fall 0.8%. The next scheduled report is December 10, 2026.

Analysts covering the stock number 59, with 66% rating the shares Buy and a consensus rating of Buy. The consensus price target was $1,092.67, 18.3% above the closing price, suggesting upside by consensus expectations despite the current premium valuation.

What to watch

• December 10, 2026: next earnings report date.
• September 24, 2026: last report, EPS $6.75 versus $6.54 expected, 3.2% above estimates.
• Price to trailing earnings of 33.5 times and price to forward earnings of 40.5 times expected earnings.
• News that Costco reduced prices on Kirkland Signature staple products, reported by Zacks Investment Research.
• Commentary criticizing aspects of Costco's Medicare-related insurance plans and noting a slowdown in overall growth to 3.8%, reported by 247 Wallst.